iDtheinvestordatabase
Home / Directory / Clay Capital
Active: new fund Oct 2025 Verified 4 Nov 2026

Clay Capital

Venture fund, formerly VisVires New Protein, investing in food and agriculture technology companies across Europe and Asia from seed to Series C, with a focus on links between human and planetary health.

Type
VC firm
Location
London, United Kingdom
Stages
Seed, Series A, Series B, Growth
Sectors
Healthtech and life sciences, Food, Agritech, Climate and cleantech

Contacts on file

For Clay Capital, the paid file holds: 8 named decision-makers with roles; LinkedIn page.

Get UK Complete, $149 Free sample

One-time payment. No subscription. No account.

Notable investments

Aleph FarmsNuritasRootwaveMiAlgaeInfinite Roots

Sources

Last checked 4 Nov 2026. Is something wrong? Tell us.

Appears in 39 lists

Agritech investors in the UK (17)Food and beverage investors in the UK (19)Series B agritech investors (24)Series B food and beverage investors (25)Growth-stage agritech investors (46)Series B investors in the UK (54)Series A food and beverage investors (65)Series A agritech investors (65)Growth-stage food and beverage investors (67)Climate tech investors in London (71)Active startup investors in the UK (73)Seed agritech investors (97)Series B climate tech investors (98)Seed food and beverage investors (106)Healthtech investors in London (113)Agritech investors (137)Growth-stage investors in the UK (137)Climate tech investors in the UK (146)Venture capital firms in London (149)Series A investors in the UK (154)Series B healthtech investors (160)Food and beverage investors (179)Growth-stage climate tech investors (189)Venture capital firms in the UK (192)Healthtech investors in the UK (194)Startup investors in London (239)Series A climate tech investors (263)Seed investors in the UK (295)Growth-stage healthtech investors (316)Series B investors (339)Series A healthtech investors (401)Startup investors in the UK (416)Seed climate tech investors (458)Climate tech investors (660)Growth-stage investors (705)Seed healthtech investors (800)Series A investors (864)Healthtech investors (1,207)Seed investors (1,892)